Search - tctmd.com

Displaying 81 - 100 of 101

Sort: Relevancy | Date

News Industry News

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

May 19, 2015

News Conference News TCT 2014

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

September 19, 2014

Presentation TCT 2014

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Juan F. Granada

September 16, 2014

Presentation TCT 2014

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Laura Mauri

September 16, 2014

Presentation TCT 2014

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Kenya Brothers

September 16, 2014

Presentation TCT 2014

Sirolimus-Eluting Balloon Angioplasty Dilatation System for ISR Indication: The SABRE Trial

Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Stefan Verheye

September 16, 2014

Presentation TCT 2014

Antirestenotic Efficacy in the Treatment of In-Stent Restenosis: A Comparison of Two Paclitaxel Drug-Eluting Balloons With Different Coatings

Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Freek Nijhoff

September 16, 2014

Presentation TCT 2014

Sirolimus Nanocrystal Balloon-Based Delivery for Coronary DES-ISR

Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Sameer I. Dani

September 16, 2014

News Daily News

对STEMI患者使用网膜支架安全，但是TLR、TVR风险比BMS高

July 08, 2014

News Daily News

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

July 08, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Industry News

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

October 09, 2013

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Industry News

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

November 02, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

Advertisement

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

Status of DCB for PVD and Lessons Learned from the Recent FDA Panel

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Sirolimus-Eluting Balloon Angioplasty Dilatation System for ISR Indication: The SABRE Trial

Antirestenotic Efficacy in the Treatment of In-Stent Restenosis: A Comparison of Two Paclitaxel Drug-Eluting Balloons With Different Coatings

Sirolimus Nanocrystal Balloon-Based Delivery for Coronary DES-ISR

对STEMI患者使用网膜支架安全，但是TLR、TVR风险比BMS高

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

PRISM Individualized Informed Consent Improves PCI Choice, Experience

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content